Table 2.
Patient demographics and disease characteristics.
| N = 55 | |
|---|---|
| Age, median (range) | 62 (44–78) |
| ECOG performance status, n (%) | |
| 0 | 49 (89.1) |
| 1 | 5 (9.0) |
| 2 | 1 (1.8) |
| Malignancy, n (%) | |
| Ovarian | 43 (72.7) |
| Primary peritoneal carcinoma | 10 (18.1) |
| Fallopian tube carcinoma | 2 (3.6) |
| Histologic subtype and tumor grade, n (%) | |
| Serous | |
| High grade | 28 (50.9) |
| Intermediate | 10 (18.2) |
| Low grade | 5 (9.1) |
| Unknown | 7 (12.7) |
| Endometrioid | |
| High grade | 1 (1.8) |
| Unknown | 1 (1.8) |
| Clear cell | 1 (1.8) |
| Mixed endometrioid/serous | |
| High grade | 1 (1.8) |
| Transitional cell | |
| High grade | 1 (1.8) |
| Platinum-free interval, months | |
| 6–12 | 10 (18.2) |
| >12–18 | 22 (40.0) |
| >18–24 | 8 (14.5) |
| >24 | 15 (27.3) |
ECOG, Eastern Cooperative Oncology Group.